No evidence of a role for activating CDK2 mutations in melanoma

Melanoma Research

Volumn 11, Issue 4, 2001, Pages 343-348

  Walker, G ^a   Hayward, N ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

CDK2; Cell cycle; Melanoma; Mutation

Indexed keywords

CELL ANTIGEN; CYCLIN DEPENDENT KINASE 2; PROTEIN P21; PROTEIN P27;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034897820     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200108000-00004     Document Type: Article

References (34)

1. The current situation with regard to human melanoma and genetic interference
2. CDKN2A mutations in melanoma
3. INK4a binding domain of CDK4 in familial melanoma
4. Prevalence of p16INK4a and CDK4 germline mutations in 48 melanoma-prone families in France
5. Novel mutations in the p16INK4a/CDKN2A binding region of the cyclin-dependent kinase-4 gene
6. CDK inhibitors: Positive and negative regulators of G1-phase progression
7. The INK4 family of cell cycle inhibitors and cancer
8. INK4a inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes
9. INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of CDK2 complexes late in G1
10. Expression of cell cycle regulators in human cutaneous malignant melanoma
11. cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain
12. INK4d
13. Characterisation of the human cyclin-dependent kinase 2 gene, promoter analysis and gene structure
14. Molecular characterisation of the melanocyte lineage-specific antigen gp100
15. Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy
16. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
17. Mouse silver mutation is caused by a single base insertion in the putative cytoplasmic domain of pmel 17
18. Identification and characterisation of a new gene physically linked to the ATM gene
19. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1
20. Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene
21. Complex regulation of the BRCA1 gene
22. A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1
23. CDKN2A/p16INK4a is inactivated in most melanoma cell lines
24. A simple salting out procedure for extracting DNA from human nucleated cells
25. Mutations of the CDKN2/p16INK4a gene in Australian melanoma kindreds
26. Control of plasminogen activator inhibitor type 2 gene expression in the differentiation of monocytic cells
27. Virtually 100% of melanoma cell lines harbour alterations within the p16INK4a/p15INK4b genes or one of their downstream targets
28. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
29. INk4a-pRb regulatory pathway in cultured melanoma cells
30. Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: A novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma
31. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
32. Cip/Kip cyclin-dependent kinase inhibitors: Brakes of the cell cycle engine during development
33. Systematic variation in gene expression patterns in human cancer cell lines
34. Molecular classification of cutaneous malignant melanoma by gene expression profiling